Immune checkpoint inhibitors and other immune therapies in breast cancer: A new paradigm for prolonged adjuvant immunotherapy
Background: Breast cancer is the most common form of cancer in women worldwide.
Advances in the early diagnosis and treatment of cancer in the last decade have …
Advances in the early diagnosis and treatment of cancer in the last decade have …
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease
MN Mills, W King, A Soyano, Y Pina… - Journal of Neuro …, 2022 - Springer
Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer are at
a particularly high risk of breast cancer brain metastasis (BCBM) and leptomeningeal …
a particularly high risk of breast cancer brain metastasis (BCBM) and leptomeningeal …
Evolutionary trend analysis of research on immunotherapy for brain metastasis based on machine-learning scientometrics
Brain metastases challenge cancer treatments with poor prognoses, despite ongoing
advancements. Immunotherapy effectively alleviates advanced cancer, exhibiting immense …
advancements. Immunotherapy effectively alleviates advanced cancer, exhibiting immense …
Immunotherapy and radiation therapy sequencing in breast cancer: a systematic review
Purpose In the past decade, immune checkpoint inhibitors (ICIs) have emerged as a
treatment option for metastatic breast cancer (BC). More recently, ICIs have been approved …
treatment option for metastatic breast cancer (BC). More recently, ICIs have been approved …
Radiotherapeutic strategies to overcome resistance of breast cancer brain metastases by considering immunogenic aspects of cancer stem cells
K Hintelmann, C Petersen, K Borgmann - Cancers, 2022 - mdpi.com
Simple Summary Modern radiotherapy offers several options for the treatment of brain
metastases from breast cancer. The radioresistant subpopulation of cancer stem cells …
metastases from breast cancer. The radioresistant subpopulation of cancer stem cells …
Long-term survival from breast cancer brain metastases in the era of modern systemic therapies
METHODS: We reviewed 190 patients with breast cancer with 931 brain tumors receiving
SRS who were followed at our institution with prospective data collection between 2012 and …
SRS who were followed at our institution with prospective data collection between 2012 and …
[HTML][HTML] Stereotactic radiosurgery and anti-PD-1+ CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional …
AE Dohm, JY Nakashima, H Kalagotla, SX Jiang… - European Journal of …, 2023 - Elsevier
Background Immunotherapy and targeted BRAF/MEK inhibitors (i) have revolutionised the
systemic management of advanced melanoma. Given the role of stereotactic radiosurgery …
systemic management of advanced melanoma. Given the role of stereotactic radiosurgery …
Triple Negative Breast Cancer and Brain Metastases
R Bansal, AED Van Swearingen… - Clinical Breast …, 2023 - clinical-breast-cancer.com
The treatment of metastatic breast cancer (MBC) has improved over the past decade,
however prognosis continues to be mitigated by the fact that about 1 in 5 patients with MBC …
however prognosis continues to be mitigated by the fact that about 1 in 5 patients with MBC …
Intracranial response rate in patients with breast cancer brain metastases after systemic therapy
A Niwinska, K Pogoda, A Jagiello-Gruszfeld… - Cancers, 2022 - mdpi.com
Simple Summary For many years, patients with breast cancer and brain metastases were
excluded from participation in clinical trials. It was believed that anticancer drugs could not …
excluded from participation in clinical trials. It was believed that anticancer drugs could not …
Phase II Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Background Screening of asymptomatic stage IV breast cancer with brain MRIs is currently
not recommended by National Comprehensive Cancer Network (NCCN) Guidelines. The …
not recommended by National Comprehensive Cancer Network (NCCN) Guidelines. The …